Effects of raloxifene on bone mineral density and biochemical markers of bone remodeling in postmenopausal women pre-treated with raloxifene or alendronate for one year.

被引：0
|
作者：
Brown, J
Ng, KW
Toss, G
Zhou, C
Wong, M
Draper, MW
机构：
[1] Ctr Hosp Univ Quebec, Ste Foy, PQ, Canada
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[4] Lilly Res Labs, Indianapolis, IN USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [41] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Aysegul Atmaca
    Olcay Gedik
    Advances in Therapy, 2006, 23 : 842 - 853
  • [42] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Atmaca, Aysegul
    Gedlik, Olcay
    ADVANCES IN THERAPY, 2006, 23 (06) : 842 - 853
  • [43] Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial
    Morii, H
    Ohashi, Y
    Taketani, Y
    Fukunaga, M
    Nakamura, T
    Itabashi, A
    Sarkar, S
    Harper, K
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 (10) : 793 - 800
  • [44] A Comparison of the Effects of Raloxifene and Hormon Therapy on Lipid Profile and Bone Mineral Density in Postmenopausal Osteopenia Women
    Jung, Min Hyung
    Choi, Hoon
    Kim, Tak
    Kim, Heung Yeol
    Lee, Byung Ick
    Park, Hyoung Moo
    Park, Ki Hyun
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (06): : 1230 - 1230
  • [45] Treatment of Postmenopausal Women with Osteoporosis or Low Bone Density with Raloxifene
    P. J. Meunier
    E. Vignot
    P. Garnero
    E. Confavreux
    E. Paris
    S. Liu-Leage
    S. Sarkar
    T. Liu
    M. Wong
    M. W. Draper
    Osteoporosis International, 1999, 10 : 330 - 336
  • [46] Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial
    H. Morii
    Y. Ohashi
    Y. Taketani
    M. Fukunaga
    T. Nakamura
    A. Itabashi
    S. Sarkar
    K. Harper
    Osteoporosis International, 2003, 14 : 793 - 800
  • [47] Effects of alendronate therapy on the bone mineral density in postmenopausal women
    Savoca, S
    Nardo, LG
    D'Agosta, S
    Messina, K
    Rosano, T
    Pignatello, R
    Nardo, F
    RECENT RESEARCH IN GYNECOLOGICAL ENDOCRINOLOGY, 2001, : 231 - 234
  • [48] Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene
    Meunier, PJ
    Vignot, E
    Garnero, P
    Confavreux, E
    Paris, E
    Liu-Leage, S
    Sarkar, S
    Liu, T
    Wong, M
    Draper, MW
    OSTEOPOROSIS INTERNATIONAL, 1999, 10 (04) : 330 - 336
  • [49] Effect of raloxifene and clodronate on bone density in postmenopausal osteoporotic women
    D'Amelio, P
    Muratore, M
    Tinelli, F
    Tamone, C
    Cosention, L
    Quarta, E
    Calcagnile, F
    Isaia, GC
    INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS, 2003, 25 (02): : 73 - 78
  • [50] Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling
    Pineda, Begona
    Hermenegildo, Carlos
    Tarin, Juan J.
    Cano, Antonio
    Angel Garcia-Perez, Miguel
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (03): : 319 - 327
12345